Sajal Gupta

Sajal Gupta

Active Director Director DIN 08804999
DIN 08804999 First appointment Jul 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2020
Shareholding value •••• Premium profile

About Sajal Gupta

Data last updated:

Sajal Gupta is a Director at Meleev Healthcare Private Limited (since 2020). The company operates in Pharma. Meleev Healthcare Private Limited reported revenue of ₹1.36 Cr (FY 2025).

DIN 08804999
Primary Designation Director
Industry Pharma
First Appointment 22 Jul 2020
Oldest Company Age 6 yrs
Largest company Meleev Healthcare Private Limited · ₹1.36 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Meleev Healthcare Private Limited U51909HR2020PTC087767
Director22 Jul 20202020₹1.36 Cr (FY 2025)Active

Board colleagues of Sajal Gupta

Directorship timeline

Open interactive timeline →
Meleev Healthcare Private Limited
Premium access

Shareholding and investment profile for Sajal Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sajal Gupta

Sajal Gupta currently holds 1 directorship: Meleev Healthcare Private Limited (Director, since 22 Jul 2020, revenue ₹1.36 Cr (FY 2025)).

Sajal Gupta was first appointed on 22 Jul 2020 as Director at Meleev Healthcare Private Limited.

The current boards of Sajal Gupta's companies include Sandeep Kumar (Meleev Healthcare Private Limited), Shubham Garg (Meleev Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available